Sopharma AD-BG11SOSOBT18-SOPHARMA

SOPHARMA AD (7/2023) "Sopharma" AD submitted for approval to the Financial Supervision Commission for an Agreement for conversion by merger of the subsidiary company "Biopharm-engineering" AD

Report no 7/2023
- 27.01.2023, 14:29
- Kategoria: Biznes i finanse
- Źródło: ESPI
SOPHARMA AD (6/2023) Publication of the Tender offering addressed to the shareholders of "Sopharma" AD by "Donev Investments Holding" AD and Opinion of the Board of Directors in connection with Art. 154 of the Law on Public Offering of Securities and Art.

Report no 6/2023
- 20.01.2023, 11:25
- Kategoria: Biznes i finanse
- Źródło: ESPI
SOPHARMA AD (5/2023) Received corrected tender offer addressed to the shareholders of "Sopharma" AD from "Donev Investments Holding" AD

Report no 5/2023
- 13.01.2023, 11:00
- Kategoria: Biznes i finanse
- Źródło: ESPI
SOPHARMA AD (4/2023) Notification from "Telso" AD under Art. 19 of Regulation (EU) No 596/2014 of 11 January 2023.

Report no 4/2023
- 12.01.2023, 09:29
- Kategoria: Biznes i finanse
- Źródło: ESPI
SOPHARMA AD (3/2023) Sales revenues for December 2022

Report no 3/2023
- 11.01.2023, 13:18
- Kategoria: Biznes i finanse
- Źródło: ESPI
SOPHARMA AD (2/2023) Notification from Ivan Badinski under Art. 19 of Regulation (EU) No 596/2014 of 12 December 2022.

Report no 2/2023
- 03.01.2023, 13:37
- Kategoria: Biznes i finanse
- Źródło: ESPI
SOPHARMA AD (1/2023) Notification from "Telso" AD under Art. 19 of Regulation (EU) No 596/2014 of 23 December 2022.

Report no 1/2023
- 03.01.2023, 09:04
- Kategoria: Biznes i finanse
- Źródło: ESPI
SOPHARMA AD (103/2022) Notification from "Telso" AD under Art. 19 of Regulation (EU) No 596/2014 of 21 December 2022.

Report no 103/2022
- 22.12.2022, 13:37
- Kategoria: Biznes i finanse
- Źródło: ESPI
SOPHARMA AD (102/2022) Notification from "Telso" AD under Art. 19 of Regulation (EU) No 596/2014 of 21 December 2022.

Report no 102/2022
- 22.12.2022, 13:31
- Kategoria: Biznes i finanse
- Źródło: ESPI
SOPHARMA AD (101/2022) Notification from "Telso" AD under Art. 19 of Regulation (EU) No 596/2014 of 20 December 2022.

Report no 101/2022
- 21.12.2022, 10:47
- Kategoria: Biznes i finanse
- Źródło: ESPI

Relacja z konferencji „Droga do prezydencji: dyskusja o priorytetach zdrowotnych polskiej prezydencji w Radzie UE”

Instytut Spraw Społecznych (1)